The aim of this study was to evaluate the ex vivo expansion of normal CD34
High-dose chemotherapy and pre-grafting regimens induce severe cytopenia, which is a cause of morbidity in marrow graft recipients. Infusion of expanded hematopoietic cells would allow reduction of this critical aplastic phase and reconstitution of an adequate graft from a smaller number of harvested cells. A great many studies of the ex vivo expansion of hematopoietic cells have been performed with this aim. [1] [2] [3] [4] [5] [6] Several investigations have been carried out to define experimental conditions for the ex vivo expansion of human precursor, progenitor and stem cell pools, in wells or T flasks, 7 or using highly purified cells and/or at very low concentration. 8 However, these procedures are clinically inadequate, due either to the risk of sample contamination or to the difficulty of manipulating excessive volumes.
In a previous study, we showed that the successful expansion of hematopoietic cells requires the establishment of well-controlled, reproducible and reliable culture conditions, notably with regard to the cell concentration in the inoculum, the composition of the culture medium 9 and the combination of stimulatory cytokines. 10 These previously defined experimental conditions were applied here to a study of the expansion of CD34 + cells from normal bone marrow in gas-permeable polypropylene bags suitable for large-scale use. The expansion potential of this culture system was investigated and in particular its capacity to expand primitive, as well as mature cells.
In order to estimate better the ability of the expanded cells to maintain their in vivo functions after infusion into patients, we analyzed various functional properties of the expanded products, such as phagocytosis and oxidative metabolism. The infusion of expanded cells to a patient compels clinicians to carefully manage their timing. Whatever the issue of the liquid culture, the patient must be preconditioned before grafting, whereas no results in terms of progeny or stem cell pools are available at the time of infusion. Therefore, we investigated the possibility of cryopreserving the final ex vivo products. Frozen expanded progenitor/stem cells were found to maintain their clonogeneic and proliferative capacities and this new approach could thus be of major interest in clinical practice by allowing clinicians to evaluate the quality of a graft before its infusion.
Materials and methods

Bone marrow (BM) cell preparation
BM cells were obtained from healthy donors for allogeneic transplantation or from patients undergoing hip surgery and all donors gave informed consent. Light-density mononuclear cells (MNC) were separated using a Ficoll-Isopaque density gradient (1.077 g/ml; Seromed, Biochrom, Berlin, Germany), washed and resuspended at a concentration of 0.5-1 × 10 8 cells/ml in PBS without Ca++ or Mg++ (Gibco, Life Technologies, Paisley, UK). CD34 + cells were selected by the Isolex TM 50 procedure (Baxter Fenwal Division, Deerfield, IL, USA) as previously described. 9 The mean CD34 + cell purity in the subsequent experiments was 93 Ϯ 3% (range: 78 to 99%).
Liquid cultures
CD34
+ cells were suspended at various concentrations (5 × 10 3 , 10 4 , 5 × 10 4 or 10 5 cells/ml) in serum-free longterm culture medium (LTCM) 11, 12 supplemented with mast cell growth factor (MGF) or stem cell factor (SCF) (100 ng/ml), FLT3-ligand (Fl) (100 ng/ml), IL3 (5 ng/ml), IL6 (10 ng/ml), and G-CSF (10 ng/ml) Ϯ MGDF (megakaryocyte growth and development factor) (100 ng/ml) or epo (0.5 U/ml) (complete LTCM). FL was kindly provided by Immunex (Washington, USA), IL3 and IL6 by Sandoz (Basel, Switzerland), Epo by Behring (Marburg, Germany) and G-CSF by Chugai Rhône-Poulenc (Ukima, Japan) and MGDF by Amgen (Thousand Oaks, CA, USA). The cell suspensions were incubated at 37°C in a 5% CO 2 /95% air atmosphere for 14 days, after which time the cells were collected, washed and analyzed for progenitor cells, LTC-IC, immunophenotype and cytology.
Cultures were performed either in gas-permeable bags or in tissue culture flasks. Using gas-permeable polypropylene + cells were seeded in 4 ml of complete LTCM according to the manufacturer's recommendations. Fresh medium containing cytokines (16 ml) was added to each bag on day 6. According to our previous studies 10 cells were removed on day l4 with a syringe and washed in IMDM prior to analysis. Using tissue culture flasks (25 cm 2 T flasks; Falcon, Heidelberg, Germany), CD34
+ cells were seeded in 4 ml of complete LTCM according to our previously published procedure. 9, 10 Fresh medium containing cytokines (4 ml) was added to each flask on day 6. On day l4, non-adherent cells were collected and mixed with adherent cells which were recovered with a rubber scraper. The viable cells were then washed in Iscove's medium and assayed for progenitors.
Progenitor cell assays
Burst forming units-erythroid (BFU-E) and colony-forming units granulocyte-macrophage (CFU-GM) were assayed in single-layer methylcellulose cultures according to Eaves and Eaves. 13 Cells were stimulated with 20 ng/ml G-CSF and GM-CSF, Chugai Rhône-Poulenc, 10 ng/ml IL-3, 3 U/ml Epo and 50 ng/ml SCF. Cell concentrations were 0.5-1 × 10 3 CD34 + cells/ml on day 0 and 2 × 10 3 -5 × 10 4 cells/ml on day 14. BFU-E and CFU-GM were scored on day 14 of culture. Colony-forming units-megakaryocyte (CFU-MK) were assayed in a plasma clot culture system according to Mitjavila et al.
14 Cells were stimulated with 10% preselected serum from aplastic patients, 20 ng/ml IL-3, 20 ng/ml IL-6 and 50 ng/ml SCF. Cell concentrations were 10 4 CD34
+ cells/ml on day 0 and 2-7 × 10 5 cells/ml on day 14. Colonies containing three or more CD61-positive cells were scored on day 12 of culture.
Limiting dilution assay for long-term culture-initiating cells (LTC-IC)
LTC-IC were assayed using a slight modification of Sutherland's method 15 and performed on stroma layers established with a murine cell line (MS5) generously provided by K Mori (Department of Biology, Niigata University, Japan). The cell line was suspended in 5 ml ␣MEM (Gibco, France) supplemented with 10% FCS in 25 cm 2 tissue culture flasks (Falcon). The cells were fed until the flasks reached confluence. Adherent cells were then trypsinized (Gibco) and replated in 96-well plates coated with 1% gelatine. On days 0 and 14 of culture, cells were seeded on the preformed feeder. Cultures were initiated in IMDM supplemented with 1% l-glutamine, 12.5% FCS and 12.5% HS (Costar, Brumath, France), kept for 4 days at 37°C and subsequently transferred to 33°C, at all times in a 5% CO 2 atmosphere.
At weekly intervals, the wells were fed by replacing half the medium. After 5 weeks of culture, the progenitor content of each well was scored at day 10 by overlaying with methylcellulose medium containing SCF, IL-3, G-CSF, GM-CSF and Epo, as described above. For determination of LTC-IC frequency, cultures were scaled down to a volume of 100 l in 96-well microtiter plates and performed at limiting dilution using 20 to 50 replicates per dilution step. Dilution steps were 100, 50, 25, 10 and five cells/well for the CD34 + fraction of day 0. The expanded population was assayed from 15 to 3 × 10 4 cells/well, taking into account the cell expansion rate. The frequency of negative wells (ie no progenitor detected in the considered well) was determined, and the frequency of LTC-IC was calculated as the concentration of cells that gave 37% negative wells, using Poisson statistics, with iterative procedures to determine the best linear fit and standard errors of this function. The CFC-generating capacity of LTC-IC was assessed by scoring the progenitors (CFU-GM and BFU-E) from all the dilutions that gave Ͼ37% negative wells (ie total CFC produced in n wells at dilutions that gave Ͼ37% negative wells/total LTC-IC in n wells, where total LTC-IC is obtained from the frequency of LTC-IC and the total number of cells in the experiment).
Freezing and thawing of expanded cells
After 14 days culture, the expanded cells were resuspended in IMDM at 2 × 10 7 cells/ml and pre-cooled to 4°C. The cells were then mixed vol/vol, drop by drop, with a precooled freezing medium containing 80% FCS and 20% Me 2 SO (dimethylsulfoxide, D2650, Sigma) in cryotubes. Overnight freezing of the tubes in a mechanical freezer at Ϫ80°C in a polystyrene box was followed by their transfer the next day to a plastic rack, still at Ϫ80°C for 1 to 3 weeks, until thawing. 16 Thawing was carried out by immersing the cryotubes in a waterbath at 39°C. The thawed cells were immediately diluted 1/20 in IMDM containing 5% bovine serum albumin and then washed once at 4°C. Viable cells were evaluated by trypan blue exclusion prior to analysis.
Flow cytometry
The cellular expression of CD34/CD45 was evaluated before and after expansion. Cells were labeled with phycoerythrin (PE)-conjugated anti-CD34 (anti-HPCA-2; Becton Dickinson, San José, CA, USA) and fluorescein isothiocyanate (FITC)-conjugated anti-CD45 (Becton Dickinson) monoclonal antibodies and isotype matched PE-and FITCconjugated antibodies were used as controls. Counts were performed in a FACScan flow cytometer (Becton Dickinson) and 10 000 events per sample were recorded and analyzed using CELL Quest software.
Functional analyses
Normal bone marrow cells served as positive control cells in functional assays. Contaminating erythrocytes in the bone marrow samples were lysed by hypotonic shock before evaluation of the functional capacity of the remaining cells.
Phagocytosis assay: Leukocyte phagocytosis was evaluated using heat-killed yeast (Saccharomyces cerevisiae, Sigma, St Quentin Fallavier, France) as the test particle. 17 Results were expressed as the mean percentage of cells having internalized Saccharomyces cerevisiae among the population of cells most apt to phagocytose, in the range namely from monocytes or metamyelocytes to segmented neutrophils. 18 Hydrogen peroxide assay: Hydrogen peroxide (H 2 O 2 ) production was measured by means of a flow cytometric assay employing 2Ј,7Ј-dichlorofluorescein-diacetate (DCFH-DA; Kodak, France), as previously described. 19 After preincubation with DCFH-DA (5 m) at 37°C for 15 min, aliquots containing 10 6 cells/ml were incubated for a further 15 min in PBS with or without 50 ng/ml PMA (phorbol myristate acetate). Mean fluorescence intensities of cells were determined using a FACScan flow cytometer. Data were analyzed with Lysis II software and the effect of PMA on H 2 O 2 production was calculated according to a stimulation index (SI; ratio of mean fluorescence intensity of stimulated cells to that of unstimulated cells).
Data analysis
Results were expressed as the fold increase by dividing the output numbers of cells, hematopoietic progenitors and LTC-IC on day 14 of culture by the respective input numbers on day 0. Statistical analyses were performed using Student's t-test for paired data in the comparison of flasks with bags and Student's t-test for unpaired data in other cases.
Results
Comparison of expansion in bags and T flasks
The expansion of hematopoietic cells in gas-permeable bags was first compared to that of the same cells seeded in T flasks (n = 3). Cultures were established at three different cell concentrations in the presence of SCF (S), IL3 (3), IL6 (6), Epo (E), FL (F) and G-CSF (G) for 14 days. Cell amplification in flasks vs bags (Table 1) was at respectively 5 × 10 3 , 10 4 and 5 × 10 4 CD34 + cells/ml: 1008-vs 2193-fold, 460-vs 1124-fold and 81-vs 223-fold (P = NS). At a given initial input, the percentages of erythroid, granulopoietic or macrophage cells were similar whatever the container (Figure 1 ). However, considering absolute values, the number of mature cells was always higher in bags as compared to flasks. No differences were observed in terms of the fold expansion of CFU-GM or BFU-E regardless of the initial cell concentration (Table 1) . LTC-IC were studied comparatively in two experiments and the level of expansion was either similar (6.7-vs 6-fold in experiment 1) or higher (6.9-vs 2.6-fold in experiment 3) in bags relative to flasks (data not shown).
Impact of the initial cell concentration
Our second objective was to examine the impact of the initial cell concentration on the expansion of BM cells in bags in the presence of S, 3, 6, E, F, G. In seven experiments, the mean (Ϯ s.e.m.) cloning efficiency of the starting population was 135 Ϯ 8 CFU-GM, 55 Ϯ 8 BFU-E, 3 Ϯ 1 CFU-MK and 96 Ϯ 6 LTC-IC per 10 3 CD34 + cells and 3.8 Ϯ 0.4 CFC were generated per LTC-IC. A linear cell concentration study was performed from 5 to 100 × 10 3
CD34
+ cells/ml under the conditions described in the Methods section. After 14 days expansion, the percentages of erythroid, monocytic and granulocytic cells among expanded cells were found to depend on the initial number of input cells to the culture (Figure 1b) . A lower initial cell input favored the production of cells with erythroid morphology, whereas a higher initial cell concentration favored the production of cells with granulocytic morphology. Increasing the cell concentration (5 × 10 3 , 10 4 , 5 × 10 4 and 10 5 CD34 + cells/ml) increased the percentage of metamyelocytic and polymorphonuclear cells in the final output (3 Ϯ 1%, 8 Ϯ 1%, 17 Ϯ 3% and 32 Ϯ 1%, respectively), while the overall granulocytic compartment was reduced almost four-fold (P = 0.007) in absolute values. As shown in Figure 2 , this same rise in initial cell concentration from 5 to 100 × 10 3 cells/ml reduced the expansion potential close to 20-fold for the total cell population (P = 0.001), five-fold for CFU-GM (P = 0.005) and 2.5-fold for BFU-E (P = 0.012). LTC-IC expansion decreased non-significantly from 5.3-to 3.3-fold, but the CFC-generating capacity of LTC-IC remained unchanged from that of day 0 irrespective of the initial cell input.
Impact of cytokine combinations
In order to appreciate whether these large-scale conditions in culture bags were able to sustain high LTC-IC and progenitor expansion at high cell concentration (ie 5 × 10 4
CD34
+ cells/ml), four experiments were performed using a combination of SCF, IL3, IL6, FL, G-CSF, MGDF (M) previously shown to be highly efficient for primitive stem cells. 10 The input per bag on day 0 was 2 Ϯ 0 × 10 5 CD34
+ cells, 1.9 Ϯ 0.1 × 10 4 CFU-GM, 9.8 Ϯ 0.8 × 10 3 BFU-E, 1.6 Ϯ 0.3 × 10 4 LTC-IC. As shown in Table 2 , the mean expansion extent was significantly greater for CFU-GM (P Ͻ 0.001), BFU-E (P = 0.024) and LTC-IC (P = 0.022) compared to a combination of SCF, IL3, IL6, FL, G-CSF and Epo. As compared to S, 3, 6, F, G, E, the frequency of LTC-IC increased dramatically (P = 0.003) in the presence of S, 3, 6, F, G, M, while the CFC-generating capacity remained constant (Table 3) . One representative experiment is illustrated in Figure 3 .
Functional analyses
The results of phagocytosis assays, evaluated in the presence of S, 3, 6, E, F, G are summarized in Table 4 . Among the cell populations with high phagocytic capacity, namely monocytes, metamyelocytes and segmented neutrophils, the percentage of phagocytic cells was similar in expanded cells derived from initial fractions containing 5 × 10 
Table 2
Extent of expansion in relatiion with the cocktail of cytokines 
Impact of cryopreservation on expanded cells
In order to explore the possibility of carrying out successful cryopreservation of expanded cells, five experiments were performed using cells from cultures initiated at 5 × 10 4
CD34
+ cells/ml in the presence of S, 3, 6, E, F, G. As shown in Figure 4 , the total viable cell recovery after thawing was 45 Ϯ 4%, while the recoveries of progenitors and LTC-IC ranged from 65 to 90%. It should be noted that the recovery yields of cells and progenitors were not affected by the initial cell concentration (data not shown).
The proliferative capacity of cryopreserved and thawed expanded cells was evaluated in three experiments. Cells from 14-day expansions were either cultured for 1 additional week or frozen at Ϫ80°C and then thawed and cultured for 1 week under the same conditions. Rates of expansion from week 2 to week 3 were similar for frozen and non-frozen cells. Thus, the mean expansion of total cells (Figure 5a ) was 2.5 Ϯ 0.3-fold and 2.7 Ϯ 0.1-fold, while that of CFC (CFU-GM + BFU-E) (Figure 5b ) was 3.4 Ϯ 0.8-fold and 3.1 Ϯ 0.2-fold for fresh and frozen cells, respectively. + cells/ml in polypropylene bags. After 2 weeks expansion in serum-free medium supplemented with SCF, IL3, IL6, Epo, FLT3-l and G-CSF, the cells were either cultured for 1 additional week (day 14 to 21), or frozen and thawed and then cultured for 1 week (day 14 to day 21). Results are expressed as the absolute number of cells or CFC generated from 1000 CD34 + cells seeded on day 0. -ȣ-, experiment 1; --, experiment 2; -̆-, experiment 3.
Discussion
Considerable efforts are currently being made to define culture conditions which enable optimal expansion of hematopoietic cells, while maintaining LTC-IC levels during precursor/progenitor cell proliferation. However, the majority of investigations to date have not been aimed at developing clinically feasible culture systems. The classical container, a T flask, does not allow easy medium replacement and requires complex manipulation, with the result that serious risks of contamination appear in some procedures. Gas-permeable bags represent an interesting alternative approach for large-scale expansion, notably through use of a closed and easily manipulated system.
In the present study, we first showed that this kind of gas-permeable bag is capable of supporting the expansion of normal CD34
+ cells in a similar manner to small-scale well or flask systems, allowing mean expansions of up to 2193-fold for total nucleated cells, 26-fold for CFU-GM and seven-fold for LTC-IC after 14 days' culture in serumfree medium supplemented with a combination of SCF, IL3, IL6, Fl, Epo and G-CSF. There is no doubt that the differences of procedures of refeeding flasks and bags may account for a bias in the comparison of the results. Nevertheless the data clearly show that gas-permeable bags are suitable for a comparatively high level of expansion of various compartments. These data are consistent with previous studies of the ex vivo expansion of hematopoietic cells using partially enriched progenitor preparations from marrow or cord blood. 5, 20 The initial input concentration of cells in the bags influenced the expansion of all hematopoietic compartments. Increasing this initial concentration induced the production of granulocytic cells with terminal differentiation while simultaneously decreasing the overall extent of expansion. These results confirm the observations of Shapiro et al 21 concerning late precursors and our own 9 for early progenitor/stem cells. The limited productivity of hematopoietic cell cultures initiated at high cell concentration may be partly due to the consumption of metabolic substrates in the medium, aggravated by the suboptimal weekly feeding protocol. 22 In order to assess the functional capacity of expanded neutrophils and monocytes, we tested their phagocytic activity and oxidative metabolism, two properties representing the terminal stages of functional granulocytic differentiation. 18 The expanded cells produced in cultures displayed lower but not negligible phagocytic activity as compared to normal control cells. Phagocytosis assays further suggested that cells derived from starting fractions containing 5 × 10 4 CD34 + cells/ml had higher functional capacity than those derived from cultures initiated at a lower cell input. A study of the potential for oxygen-dependent microbe killing by production of hydrogen peroxide 23 showed that the expanded cells produced hydrogen peroxide upon stimulation by PMA, although in lesser quantities than control bone marrow cells. Expansions initiated at 5 × 10 4 cells/ml gave rise to slightly more functional cells than expansions initiated at 10 5 cells/ml, with a similarly responsive population. The expanded cells were also capable of adhering to an FCS-coated surface after stimulation with PMA and of migrating towards chemotactic agents such as C5a or fMLP (data not shown). Taken overall, these results suggest that the cultured cells had the capacity to perform the biological functions essential to host defense against bacterial infection, even if these functions were never equivalent to those of control cells from normal bone marrow. The differences in functional capacity between expanded and non-expanded cells may reflect various effects of in vitro cell differentiation on the terminal maturation process. IFN-␥ could be used to induce the terminal maturation of cultured cells, since it has been reported to increase most of the functional activities of neutrophils 24 and monocytes. 25 BFU-E/kg and 6.2 × 10 5 LTC-IC/kg for a patient of 70 kg. Such an expansion would require only 500 ml of culture medium, which is clinically relevant. In fact, these figures suggest that reduced volumes of bone marrow could be expanded ex vivo in bags, with a view to potential clinical applications for transplantation.
It is of major importance for the clinician to collect, prior to its infusion to the patient, all parameters relating to the expanded product. The possibility of freezing expanded cells has not yet been investigated. Our data clearly demonstrate that it is possible to cryopreserve expanded progenitor/stem cells, including E-LTC-IC (extended LTC-IC, evaluated after 10 weeks on murine stroma), the recovery of which after thawing was 81 Ϯ 7% (data not shown), although as expected the mature cells were less well recovered. 29 These results were confirmed at the functional level since the cryopreserved cells maintained their proliferative capacity. Thus the freezing step may be considered as no more than an interruption, without any influence on the capacity of the cells to further expand in vivo. Neverthe- less, as one cannot ignore the impact of the loss of mature cells after thawing which would probably influence the short phase of hematopoietic recovery, evaluation of the expanded graft prior to its reinfusion must remain of considerable interest in order to facilitate the planning of clinical and laboratory requirements.
In conclusion, the present study would suggest that the experimental conditions are critical parameters which can affect the extent of expansion of the various hematopoietic pools, as well as the functional capacity of the mature cell produced. This study also demonstrated that ex vivo expanded cells can be frozen without altering their proliferative capacity and taking into account the specifications mentioned above, these experimental conditions meet the criteria for potential clinical use.
